Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

Vascular Biogenics Ltd.

VBL Therapeutics, is a clinical stage biopharmaceutical company focused on discovery, development and commercialization of first-in-class treatments for cancer.
Raised
$24.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,489,422
Grant - 2017
Israel Innovation Authority
$22,000,000
Secondary market - 2016
Team Size
10+
Employees
$2,489,422 Grant
GEN

VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy Genetic Engineering & Biotechnology News - Biotec...